-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $665

Benzinga·07/24/2026 18:39:01
Listen to the news
Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $586 to $665.